<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Rheumatol</journal-id><journal-id journal-id-type="iso-abbrev">J Rheumatol</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>The Journal of rheumatology</journal-title></journal-title-group><issn pub-type="ppub">0315-162X</issn><issn pub-type="epub">1499-2752</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10066823</article-id><article-id pub-id-type="pmcid-ver">PMC10066823.1</article-id><article-id pub-id-type="pmcaid">10066823</article-id><article-id pub-id-type="pmcaiid">10066823</article-id><article-id pub-id-type="manuscript-id">NIHMS1844871</article-id><article-id pub-id-type="pmid">36379579</article-id><article-id pub-id-type="doi">10.3899/jrheum.220822</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1844871</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1844871</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Long-term opioid therapy among patients with systemic lupus erythematosus in the community. A Lupus Midwest Network study</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Figueroa-Parra</surname><given-names initials="G">Gabriel</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-6077-8899</contrib-id><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jeffery</surname><given-names initials="MM">Molly M.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3854-6810</contrib-id><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dabit</surname><given-names initials="JY">Jesse Y.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chevet</surname><given-names initials="B">Baptiste</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9646-7603</contrib-id><xref rid="A1" ref-type="aff">1</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Valenzuela-Almada</surname><given-names initials="MO">Maria O.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hocaoglu</surname><given-names initials="M">Mehmet</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Osei-Onomah</surname><given-names initials="SA">Shirley-Ann</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kurani</surname><given-names initials="S">Shaheen</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2366-7505</contrib-id><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Vallejo</surname><given-names initials="S">Sebastian</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Achenbach</surname><given-names initials="SJ">Sara J.</given-names></name><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hooten</surname><given-names initials="WM">W. Michael</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5645-6355</contrib-id><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Barbour</surname><given-names initials="KE">Kamil E.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0546-6742</contrib-id><xref rid="A7" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Crowson</surname><given-names initials="CS">Cynthia S.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5847-7475</contrib-id><xref rid="A1" ref-type="aff">1</xref><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Duarte-Garc&#237;a</surname><given-names initials="A">Al&#237;</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-1749-5719</contrib-id><xref rid="A1" ref-type="aff">1</xref><xref rid="A4" ref-type="aff">4</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.</aff><aff id="A2"><label>2</label>Division of Health Care Delivery Research, Mayo Clinic, Rochester, Minnesota, USA.</aff><aff id="A3"><label>3</label>Division of Rheumatology, Brest Teaching Hospital, Brest, France; LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France.</aff><aff id="A4"><label>4</label>Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA.</aff><aff id="A5"><label>5</label>Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.</aff><aff id="A6"><label>6</label>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.</aff><aff id="A7"><label>7</label>Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1"><bold>Author contributions:</bold> GFP, MMJ, JYD, BC, MOVA, CSC, and ADG contributed to the study conception and design. Material preparation and data collection were performed by GFP, MMJ, JYD, MOVA, SOO, SK, SV, and SJA. Analyses of data were performed by SJA and CSC. Interpretation of results was made by GFP, MMJ, JYD, BC, SJA, WMH, KEB, CSC, and ADG. SJA, CSC and ADG verified the underlying data. The first draft of the manuscript was written by GFP and ADG. All authors read and approved the final manuscript.</p></fn><corresp id="CR1"><bold>Corresponding author:</bold> Al&#237; Duarte-Garc&#237;a MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, Phone: 507-284-2060, Fax: 507-284-0564, <email>duarte.ali@mayo.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>4</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>15</day><month>11</month><year>2022</year></pub-date><volume>50</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">432530</issue-id><fpage>504</fpage><lpage>511</lpage><pub-history><event event-type="nihms-submitted"><date><day>27</day><month>10</month><year>2022</year></date></event><event event-type="pmc-release"><date><day>01</day><month>04</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>04</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 05:25:25.783"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1844871.pdf"/><abstract id="ABS1"><sec id="S1"><title>Objective</title><p id="P2">There is little information about the epidemiology and factors associated with opioid therapy in systemic lupus erythematosus (SLE). We aimed to assess the prevalence of opioid therapy and explore factors associated with long-term opioid therapy (LTOT) in patients with SLE.</p></sec><sec id="S2"><title>Methods</title><p id="P3">Patients with SLE were matched with non-SLE controls in a population-based cohort on January 1, 2015. We captured demographics, manifestations of lupus, comorbidities (fibromyalgia, mood disorders, osteoarthritis, chronic low back pain [CLBP], chronic kidney disease, avascular necrosis, osteoporosis, fragility fractures, and cancer), and the area deprivation index (ADI). Opioid prescription data were used to assess prevalence of LTOT, defined as contiguous prescriptions (gaps of &lt;30 days between prescriptions) and receiving opioid therapy &#8805;90 days or &#8805;10 prescriptions before index date.</p></sec><sec id="S3"><title>Results</title><p id="P4">465 SLE patients and 465 non-SLE controls were included; 13% of SLE patients and 3% of non-SLE controls were receiving opioid therapy (<italic toggle="yes">P</italic>&lt;0.001), and 11% of SLE patients were on LTOT versus 1% of non-SLE controls. Among SLE patients, acute pericarditis (OR: 3.92; 95% CI: 1.78&#8211;8.66), fibromyalgia (OR: 7.78; 95% CI: 3.89&#8211;15.55), fragility fractures (OR: 3.72; 95% CI: 1.25&#8211;11.07), CLBP (OR: 4.00; 95% CI: 2.13&#8211;7.51), and mood disorders (OR: 2.76; 95% CI: 1.47&#8211;5.16) were associated with LTOT. We did not find an association between opioid therapy and ADI.</p></sec><sec id="S4"><title>Conclusion</title><p id="P5">Patients with SLE have higher LTOT than controls. Among patients with SLE, LTOT was associated with pericarditis and several comorbidities. However, LTOT was not associated with kidney disease despite the limited pain control options in these patients.</p></sec></abstract><kwd-group><title>Key Indexing Terms:</title><kwd>Systemic lupus erythematosus</kwd><kwd>opioids</kwd><kwd>pain management</kwd><kwd>long-term opioid therapy</kwd><kwd>comorbidity</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>